Annexin A5 in Patients With Severe COVID-19 Disease
Condition(s):Coronavirus Infection; SepsisLast Updated:March 8, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Coronavirus Infection; SepsisLast Updated:March 8, 2023Completed
Condition(s):Retinal Vein OcclusionLast Updated:August 31, 2023Recruiting
Condition(s):Carotid Atherosclerosis; Atherosclerotic PlaqueLast Updated:October 20, 2021Withdrawn
Condition(s):Retinal Vein OcclusionLast Updated:February 5, 2024Recruiting
Condition(s):Endocarditis; ThrombosisLast Updated:August 26, 2021Terminated
Condition(s):AMPD; Ischemic ToleranceLast Updated:April 22, 2016Completed
Condition(s):Ischemia-Reperfusion Injury; The Metabolic SyndromeLast Updated:August 24, 2010Completed
Condition(s):Cardiovascular Disease; Ischemia-reperfusion Injury; PostconditioningLast Updated:November 10, 2015Withdrawn
Condition(s):Sleep DisturbanceLast Updated:December 5, 2023Not yet recruiting
Condition(s):Caffeine; Ischemic Preconditioning; Ischemia-Reperfusion InjuryLast Updated:November 29, 2006Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.